Shilei Ding

4.8k total citations
61 papers, 2.0k citations indexed

About

Shilei Ding is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Shilei Ding has authored 61 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Virology, 32 papers in Infectious Diseases and 31 papers in Immunology. Recurrent topics in Shilei Ding's work include HIV Research and Treatment (42 papers), Immune Cell Function and Interaction (23 papers) and HIV/AIDS drug development and treatment (17 papers). Shilei Ding is often cited by papers focused on HIV Research and Treatment (42 papers), Immune Cell Function and Interaction (23 papers) and HIV/AIDS drug development and treatment (17 papers). Shilei Ding collaborates with scholars based in Canada, United States and China. Shilei Ding's co-authors include Andrés Finzi, Qinghua Pan, Shan‐Lu Liu, Chen Liang, Jonathan Richard, Chen Liang, Jérémie Prévost, Minghua Li, Fengwen Xu and Fei Guo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Shilei Ding

59 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shilei Ding Canada	24	1.2k	1.1k	858	455	386	61	2.0k
Laura M. Walker United States	22	1.2k 1.0×	967 0.9×	1.0k 1.2×	553 1.2×	726 1.9×	41	2.5k
Catarina E. Hioe United States	27	1.1k 1.0×	1.1k 1.0×	479 0.6×	416 0.9×	532 1.4×	82	1.9k
Peter Rusert Switzerland	22	1.3k 1.1×	750 0.7×	622 0.7×	268 0.6×	392 1.0×	34	1.7k
Carol D. Weiss United States	27	1.6k 1.4×	756 0.7×	1.2k 1.4×	775 1.7×	669 1.7×	65	2.6k
Hiromi Imamichi United States	27	2.1k 1.8×	1.2k 1.1×	1.4k 1.6×	571 1.3×	588 1.5×	48	3.0k
Molly A. Accola United States	17	1.0k 0.9×	490 0.4×	665 0.8×	379 0.8×	571 1.5×	31	1.8k
Baoshan Zhang United States	26	1.1k 1.0×	752 0.7×	632 0.7×	614 1.3×	648 1.7×	74	2.2k
Stéphanie Jost United States	23	924 0.8×	1.6k 1.4×	619 0.7×	706 1.6×	277 0.7×	50	2.5k
Ruben M. Markosyan United States	19	797 0.7×	517 0.5×	624 0.7×	549 1.2×	585 1.5×	24	1.7k

Countries citing papers authored by Shilei Ding

Since Specialization

Citations

This map shows the geographic impact of Shilei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilei Ding more than expected).

Fields of papers citing papers by Shilei Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilei Ding. The network helps show where Shilei Ding may publish in the future.

Co-authorship network of co-authors of Shilei Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Shilei Ding. A scholar is included among the top collaborators of Shilei Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilei Ding. Shilei Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benlarbi, Mehdi, Guillaume Beaudoin-Bussières, Shilei Ding, et al.. (2025). Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon. Virology. 605. 110467–110467. 1 indexed citations

Richard, Jonathan, Shilei Ding, & Andrés Finzi. (2025). The emerging role of small CD4 mimetic compounds in HIV-1 immunotherapy. Current Opinion in HIV and AIDS. 21(1). 20–30.

Liu, Tingting, Shiqi Hu, Shilei Ding, et al.. (2025). Algorithm assisted comprehensive optimization of SPR sensors towards single molecule detection. Biosensors and Bioelectronics. 289. 117846–117846. 2 indexed citations

Chatterjee, Debashree, Ling Niu, Halima Medjahed, et al.. (2025). A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120. Journal of Virology. 99(4). e0226724–e0226724.

Grunst, Michael W., Zhuan Qin, Shilei Ding, et al.. (2024). Structure and inhibition of SARS-CoV-2 spike refolding in membranes. Science. 385(6710). 757–765. 20 indexed citations

Hu, Shiqi, Xin Xiong, Tingting Liu, et al.. (2023). Universal and flexible design for high-sensitivity and wide-ranging surface plasmon resonance sensors based on a three-dimensional tuning hypersurface. Sensors and Actuators B Chemical. 380. 133284–133284. 10 indexed citations

Leonhardt, Susan A., Michael D. Purdy, Jonathan R. Grover, et al.. (2023). Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry. Nature Communications. 14(1). 4368–4368. 16 indexed citations

Ding, Shilei, William D. Tolbert, Lorie Marchitto, et al.. (2023). Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC. Viruses. 15(5). 1185–1185. 7 indexed citations

Tolbert, William D., Yaozong Chen, Lulu Sun, et al.. (2023). The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11. Frontiers in Immunology. 14. 1178355–1178355. 4 indexed citations

10.

Yang, Ziwei, Yang Han, Shilei Ding, et al.. (2022). SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy. mBio. 13(1). e0322721–e0322721. 48 indexed citations

11.

Gong, Shang Yu, Shilei Ding, Mehdi Benlarbi, et al.. (2022). Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2. Viruses. 14(10). 2178–2178. 9 indexed citations

12.

Braun, Anthony R., Shilei Ding, Neeraj K. Mishra, et al.. (2022). Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry. ACS Infectious Diseases. 8(10). 2045–2058. 4 indexed citations

13.

Kuwata, Takeo, William D. Tolbert, Jonathan Richard, et al.. (2022). Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates. Journal of Virology. 97(1). e0163822–e0163822. 4 indexed citations

14.

Vézina, Dani, Shang Yu Gong, William D. Tolbert, et al.. (2020). Stabilizing the HIV-1 Envelope Glycoprotein State 2A Conformation. Journal of Virology. 95(5). 8 indexed citations

15.

Ding, Shilei, Dani Vézina, Jean-Philippe Chapleau, et al.. (2019). Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity. ACS Medicinal Chemistry Letters. 11(3). 371–378. 10 indexed citations

16.

Richard, Jonathan, Jérémie Prévost, Nirmin Alsahafi, Shilei Ding, & Andrés Finzi. (2017). Impact of HIV-1 Envelope Conformation on ADCC Responses. Trends in Microbiology. 26(4). 253–265. 61 indexed citations

17.

Ding, Shilei, Amy M. Princiotto, Bruno Melillo, et al.. (2016). Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Nonhuman Primates. AIDS Research and Human Retroviruses. 33(5). 428–431. 21 indexed citations

18.

Jia, Rui, Shilei Ding, Qinghua Pan, et al.. (2015). The C-Terminal Sequence of IFITM1 Regulates Its Anti-HIV-1 Activity. PLoS ONE. 10(3). e0118794–e0118794. 29 indexed citations

19.

Ding, Shilei, Qinghua Pan, Shan‐Lu Liu, & Chen Liang. (2014). HIV-1 mutates to evade IFITM1 restriction. Virology. 454-455. 11–24. 33 indexed citations

20.

Liu, Zhenlong, Qinghua Pan, Shilei Ding, et al.. (2013). The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection. Cell Host & Microbe. 14(4). 398–410. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact